Abstract 4711: The PI3K-δ inhibitor TGR-1202 in combination with Brentuximab Vedotin (SGN-35) synergistically induces G2/M phase arrest and cell death via inhibition of tubulin polymerization in Hodgkin lymphoma cell lines
Keyword(s):
M Phase
◽
2015 ◽
Keyword(s):
Keyword(s):
Keyword(s):
2010 ◽
Vol 177
(6)
◽
pp. 3081-3088
◽
Keyword(s):
2011 ◽
Vol 39
(8)
◽
pp. 850-858
◽
Keyword(s):
2008 ◽
Vol 122
(4)
◽
pp. 769-776
◽
Keyword(s):
2015 ◽
Vol 16
(11)
◽
pp. 1651-1659
◽